Notice Pursuant to the National Cooperative Research and Production Act of 1993-Unified Extensible Firmware Interface Forum, 14295 [2014-05451]
Download as PDF
<![CDATA[
14295
Federal Register / Vol. 79, No. 49 / Thursday, March 13, 2014 / Notices
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Antitrust Division
Drug Enforcement Administration
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Unified Extensible
Firmware Interface Forum
Importer of Controlled Substances;
Notice of Registration; Cerilliant
Corporation
TKELLEY on DSK3SPTVN1PROD with NOTICES
Notice is hereby given that, on
February 5, 2014, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Unified Extensible Firmware Interface
Forum (‘‘UEFI Forum’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing (1) the name and
principal place of business of the
standards development organization
and (2) the nature and scope of its
standards development activities. The
notifications were filed for the purpose
of invoking the Act’s provisions limiting
the recovery of antitrust plaintiffs to
actual damages under specified
circumstances.
Pursuant to Section 6(b) of the Act,
the name and principal place of
business of the standards development
organization is: Unified Extensible
Firmware Interface Forum, Beaverton,
OR. The nature and scope of UEFI
Forum’s standards development
activities are: UEFI Forum members,
through the Forum’s Working Groups,
develop, manage, and promote UEFI
Specifications and the Advanced
Configuration and Power Interface
(‘‘ACPI’’) Specification—which are
voluntary consensus standards under
the Act—and Test Suites to test
compliance with these Specifications.
The purpose of these Specifications is to
simplify and secure platform
initialization and firmware boot up
operations. UEFI Forum’s members are
industry-leading technology companies,
whose consensus efforts promote
business and technological efficiency,
improve performance and security,
facilitate interoperability between
devices, platforms and systems, and
enable next-generation technologies to
emerge.
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2014–05451 Filed 3–12–14; 8:45 am]
BILLING CODE 4410–CW–P
VerDate Mar<15>2010
17:33 Mar 12, 2014
Jkt 232001
Drug
By Notice dated November 5, 2013,
and published in the Federal Register
on November 18, 2013, 78 FR 69130,
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78665–2402, made application to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
the following basic classes of controlled
substances:
Drug
Schedule
Methaqualone (2565) ...................
JWH-250 (6250) ...........................
SR-18 also known as RCS-8
(7008).
XLR11 (7011) ...............................
JWH-019 (7019) ...........................
AKB48 (7048) ...............................
JWH-081 (7081) ...........................
SR-19 also known as RCS-4
(7104).
JWH-122 (7122) ...........................
UR-144 (7144) ..............................
AM-2201 (7201) ...........................
JWH-203 (7203) ...........................
Parahexyl (7374) ..........................
2C-T-2 (7385) ...............................
JWH-398 (7398) ...........................
5-Methoxy-3,4-methylenedioxyamphetamine (7401).
N-Hydroxy-3,4-methylenedioxyamphetamine (7402).
Bufotenine (7433) .........................
N-Ethyl-1-phenylcyclohexylamine
(7455).
1-(1-Phenylcyclohexyl)pyrrolidine
(7458).
1-[1-(2Thienyl)cyclohexyl]piperidine
(7470).
2C-D (7508) ..................................
2C-E (7509) ..................................
2C-H (7517) ..................................
2C-I (7518) ...................................
2C-C (7519) ..................................
2C-N (7521) ..................................
2C-P (7524) ..................................
2C-T-4 (7532) ...............................
AM-694 (7694) .............................
Codeine methylbromide (9070) ....
Acetylmethadol (9601) .................
Allylprodine (9602) .......................
Alphacetylmethadol except levoalphacetylmethadol (9603).
Alphameprodine (9604) ................
Alphamethadol (9605) ..................
Betacetylmethadol (9607) ............
Betameprodine (9608) ..................
Betamethadol (9609) ....................
Betaprodine (9611) .......................
Hydroxypethidine (9627) ..............
Noracymethadol (9633) ................
Norlevorphanol (9634) ..................
Normethadone (9635) ..................
Para-Fluorofentanyl (9812) ..........
PO 00000
Frm 00084
Fmt 4703
Sfmt 9990
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
3-Methylfentanyl (9813) ................
Alpha-methylfentanyl (9814) ........
Acetyl-alpha-methylfentanyl
(9815).
Beta-hydroxyfentanyl (9830) ........
Beta-hydroxy-3-methylfentanyl
(9831).
Alpha-methylthiofentanyl (9832) ...
3-Methylthiofentanyl (9833) ..........
Thiofentanyl (9835) ......................
Lisdexamfetamine (1205) .............
Glutethimide (2550) ......................
Nabilone (7379) ............................
1-Phenylcyclohexylamine (7460)
1-Piperidinocyclohexanecarbo
nitrile (8603).
Alphaprodine (9010) .....................
Hydrocodone (9193) .....................
Levomethorphan (9210) ...............
Levorphanol (9220) ......................
Noroxymorphone (9668) ..............
Racemethorphan (9732) ..............
Remifentanil (9739) ......................
Carfentanil (9743) .........................
Tapentadol (9780) ........................
Schedule
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances for
manufacture and distribution to their
research and forensic customers
conducting drug testing and analysis.
The DEA has considered the factors in
21 U.S.C. 823(a) and 952(a) and
determined that the registration of
Cerilliant Corporation to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA has investigated Cerilliant
Corporation to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: February 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2014–05499 Filed 3–12–14; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\13MRN1.SGM
13MRN1
]]>Agencies
[Federal Register Volume 79, Number 49 (Thursday, March 13, 2014)]
[Notices]
[Page 14295]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05451]
[[Page 14295]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Unified Extensible Firmware Interface Forum
Notice is hereby given that, on February 5, 2014, pursuant to
Section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Unified Extensible Firmware
Interface Forum (``UEFI Forum'') has filed written notifications
simultaneously with the Attorney General and the Federal Trade
Commission disclosing (1) the name and principal place of business of
the standards development organization and (2) the nature and scope of
its standards development activities. The notifications were filed for
the purpose of invoking the Act's provisions limiting the recovery of
antitrust plaintiffs to actual damages under specified circumstances.
Pursuant to Section 6(b) of the Act, the name and principal place
of business of the standards development organization is: Unified
Extensible Firmware Interface Forum, Beaverton, OR. The nature and
scope of UEFI Forum's standards development activities are: UEFI Forum
members, through the Forum's Working Groups, develop, manage, and
promote UEFI Specifications and the Advanced Configuration and Power
Interface (``ACPI'') Specification--which are voluntary consensus
standards under the Act--and Test Suites to test compliance with these
Specifications. The purpose of these Specifications is to simplify and
secure platform initialization and firmware boot up operations. UEFI
Forum's members are industry-leading technology companies, whose
consensus efforts promote business and technological efficiency,
improve performance and security, facilitate interoperability between
devices, platforms and systems, and enable next-generation technologies
to emerge.
Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2014-05451 Filed 3-12-14; 8:45 am]
BILLING CODE 4410-CW-P
